Literature DB >> 7947765

Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin.

I I Mathews1, K P Padmanabhan, A Tulinksy, J E Sadler.   

Abstract

The crystallographic structure has been determined of a complex between a nonadecapeptide from the fifth epidermal growth factor (EGF5) domain of human thrombomodulin and human D-PheProArg-alpha-thrombin. The peptide corresponds to amino acid residues Glu408-Glu426 of thrombomodulin and contains the third disulfide loop of EGF5 and its linker to EGF6. The structure was refined at 3.0-A resolution to an R-value of 0.146. There are two thrombin molecules in the asymmetric unit, and the structure in the crystal is a 2:1 thrombin complex. The folding of the peptide corresponds closely to the third disulfide loop of EGF2 of factor Xa (rms delta = 1.0 A). The peptide is squeezed between cofacial electropositive fibrinogen recognition exo sites of the two thrombin molecules. Since the peptide has a total of seven aspartic and glutamic acid residues, the principal binding interaction with thrombin is electrostatic. A major hydrophobic association, which is highly directional in such a pronounced electrostatic environment, involves a TyrIleLeu triplet of the peptide and Phe34, Leu65, Tyr76, and Ile82 (chymotrypsinogen numbering) of one thrombin molecule. The tyrosine of the peptide is sandwiched between the thrombin aromatic rings and is most likely the prime source of the specificity of the thrombomodulin-thrombin interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947765     DOI: 10.1021/bi00250a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP.

Authors:  Yogendra Patel; Valerie J Gillet; Gianpaolo Bravi; Andrew R Leach
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

2.  Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin.

Authors:  R Hrabal; E A Komives; F Ni
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

3.  Theory of allosteric effects in serine proteases.

Authors:  E Di Cera; K P Hopfner; Q D Dang
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

4.  Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug.

Authors:  P Fuentes-Prior; C Noeske-Jungblut; P Donner; W D Schleuning; R Huber; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Identification of functional endothelial protein C receptor in human plasma.

Authors:  S Kurosawa; D J Stearns-Kurosawa; N Hidari; C T Esmon
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector.

Authors:  R De Cristofaro; M Picozzi; E De Candia; B Rocca; R Landolfi
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  An allosteric switch controls the procoagulant and anticoagulant activities of thrombin.

Authors:  O D Dang; A Vindigni; E Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 8.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04

9.  Identification of protein-protein interfaces by decreased amide proton solvent accessibility.

Authors:  J G Mandell; A M Falick; E A Komives
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 10.  Thrombin domains: structure, function and interaction with platelet receptors.

Authors:  Raimondo De Cristofaro; Erica De Candia
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.